Understanding a new protein in malaria-causing parasites
Characterizing a novel Plasmodium cytoskeletal protein
This study is looking at a new protein in the malaria parasite that helps it invade and multiply in our red blood cells, with the hope that understanding this process will lead to better treatments for malaria.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Harvard Medical School NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-11007191 on NIH RePORTER |
What this research studies
This research investigates a newly discovered protein in the malaria parasite Plasmodium falciparum, which plays a crucial role in its life cycle. The study focuses on how this protein contributes to the parasite's ability to invade human red blood cells and reproduce. By examining the cytoskeletal structures of the parasite, researchers aim to uncover mechanisms that could lead to new treatments for malaria. Patients may benefit from insights gained that could inform the development of more effective anti-malarial drugs.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals living in malaria-endemic regions who may be at risk of infection.
Not a fit: Patients who are not at risk of malaria or those who have already been effectively treated for the disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of new treatments that more effectively combat malaria.
How similar studies have performed: Other research has shown success in targeting similar proteins in malaria parasites, indicating a promising avenue for new therapeutic strategies.
Where this research is happening
Boston, United States
- Harvard Medical School — Boston, United States (Active)
Researchers
- Principal investigator: Navarro, Francesca Maria — Harvard Medical School
- Study coordinator: Navarro, Francesca Maria
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.